In this study, we have analyzed this process by generating novel transgenic mice that enabled the identification of podoplanin (Pdpn)-expressing lymphatic endothelial cells, as well as the controlled depletion of these cells during lymphangiogenesis in breast cancer progression. This evidence concerns the gene PDPN and breast cancer.